Clinical Trial: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Participants Via Single Intravenous Infusion

U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07487545) titled 'Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Participants Via Single Intravenous Infusion' on March 17.

Brief Summary: This is a randomized, double-blind, placebo-controlled, single ascending dose phase I clinical study to evaluate the safety, tolerability, PK, preliminary PD and immunogenicity of SSS67 in healthy adult participants after single intravenous infusion.

The primary objective is to assess the safety and tolerability of SSS67 following single ascending doses.

The secondary objectives are to characterize the PK, PD, and anti-drug antibody (ADA) profiles of SSS67 ...